Background and Objective Pulmonary arterial hypertension(PAH)is a pathophysiological disorder characterized by increased pulmonary arterial pressure and pulmonary vascular remodeling,its mechanism remains unclear.Tran...Background and Objective Pulmonary arterial hypertension(PAH)is a pathophysiological disorder characterized by increased pulmonary arterial pressure and pulmonary vascular remodeling,its mechanism remains unclear.Transforming growth factor-β(TGF-β)family plays a pivotal role in pulmonary arterial hypertension.SB525334 is a selective inhibitor of TGF-βreceptor 1,this study aimed to investigate the effects of SB525334 on the alleviation of monocrotalineinduced pulmonary hypertension.展开更多
文摘Background and Objective Pulmonary arterial hypertension(PAH)is a pathophysiological disorder characterized by increased pulmonary arterial pressure and pulmonary vascular remodeling,its mechanism remains unclear.Transforming growth factor-β(TGF-β)family plays a pivotal role in pulmonary arterial hypertension.SB525334 is a selective inhibitor of TGF-βreceptor 1,this study aimed to investigate the effects of SB525334 on the alleviation of monocrotalineinduced pulmonary hypertension.